Psychotropic drug treatment of mentally retarded;PSYCHOPHARMAKATHERAPIE BEI GEISTIG BEHINDERTEN

Psychopharmakotherapie

Volumn 5, Issue 2, 1998, Pages 76-80

  Häßler, Frank ^a  

^a Institut für Medizinische Psychologie und Medizinische Soziologie   (Germany)

Author keywords

Behavior; Mental retardation; Problems; Psychopharmacological treatment; Zuclopenthixol

Indexed keywords

BROMPERIDOL; CARBAMAZEPINE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOMETHIAZOLE; CLOZAPINE; DIAZEPAM; DIPHENHYDRAMINE; FLUPHENAZINE; HALOPERIDOL; MELPERONE; METOFENAZATE; NEUROLEPTIC AGENT; PERICIAZINE; PIPAMPERONE; PROMETHAZINE; PSYCHOTROPIC AGENT; RISPERIDONE; SERTINDOLE; ZUCLOPENTHIXOL; ZUCLOPENTHIXOL DECANOATE;

AGGRESSIVENESS; ARTICLE; BEHAVIOR DISORDER; DISABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; RESIDENTIAL CARE; RESTLESSNESS; SYMPTOMATOLOGY;

EID: 0031807204     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Brenner HD, Merlo M, Genner R. Die neue Rolle der Psychiatrie in der Betreuung Geistigbehinderter. Schw Archiv Neuro Psychiat 1994;145:26-34.
2. Gaedt C. Psychopharmakotherapie bei Menschen mit geistiger Behinderung. In: Dosen A, Hrsg. Psychische Erkrankungen und psychische Störungen bei Menschen mit geistiger Behinderung. Stuttgart: Gustav Fischer, 1995: 287-333.
3. Holmes N, Shah A, Wing L. The Disability Assessment Schedule: a brief screening device for use with the mentally retarded. Psychol Med 1982;12:879-90.
4. Izmeth M, Khan SY, Kumarjeewa DI. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients. Pharmacotherapeutica 1988;5:217-27.
5. Karsten D, Kivimaeki T, Linna SL. Neuroleptic treatment of oligophrenic patients. Acta Psychiatr Scand 1981;64(Suppl 294):39-45.
6. Meins W, Auwetter J, Krausz M, Turnier Y. Behandlung mit Psychopharmaka in unterschiedlichen Einrichtungen für geistig Behinderte. Nervenarzt 1993;64:451-5.
7. Menolascino FJ. Mental illness in the mentally retarded: Diagnostic and treatment issues. In: Stark JA, Menolascino FJ, Albarelli MH, Gray VC, editors. Mental Retardation and Mental Health. New York: Springer, 1988:145-55.
8. Rutter M, Tizard J, Whitemore K. Education, Health and Behavior. London: Langmans, 1970.
9. Singh I, Owino WJ. A double-blind comparison of zuclopenthixol tablets with placebo in the treatment of mentally handicapped inpatients with associated behavioral problems. J Intell Disab Res 1992;36:541-9.